Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial

David Cella, Viktor Grünwald, Bernard Escudier, Hans J. Hammers, Saby George, Paul Nathan, Marc‐Oliver Grimm, Brian I. Rini, Justin Doan, Cristina Ivanescu,

The Lancet Oncology · 2019 · 254 citations · 26 references

DOIFull text

Open access

Concepts

References

26